Please login to the form below
Scott Gottlieb
This page shows the latest Scott Gottlieb news and features for those working in and with pharma, biotech and healthcare.
Gilead reports remdesivir cuts risk of death in severe COVID-19 patients
Former US Food and Drug Administration (FDA) commissioner Scott Gottlieb also said that rigorous confirmation is needed to further support the data, tweeting that “this is very encouraging but needs to
Latest news
-
UPDATED: Senate officially confirms Stephen Hahn as FDA commissioner
He was also backed by previous FDA commissioner Scott Gottlieb, who endorsed Sharpless as “an outstanding physician and scientist who is deeply committed to public health goals” who he hoped would
-
Mega-mergers dominate as buoyant markets lift biopharma
now former FDA commissioner Scott Gottlieb.
-
FDA will maintain the pace, vows Woodcock, but warns of skills gap
Top official unconcerned by dip in approval rate. The departure of Scott Gottlieb in April robbed the FDA of one of its most dynamic ever Commissioners, and industry observers have been ... Before Gottlieb departed earlier this year, he unveiled a new
-
Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows
Will join Pfizer board. Just 83 days after leaving his Commissioner role at the FDA, Scott Gottlieb has joined the board of big pharma group Pfizer. ... We are fortunate to have D. Gottlieb join Pfizer’s Board of Directors,” said Pfizer executive
-
Verily unveils next-gen trials alliance with Novartis, Pfizer
There is also no doubt that regulators are keen to see the industry update its practices. Shortly before he stepped down as FDA commissioner earlier this year, Scott Gottlieb expressed his
More from news
Approximately 5 fully matching, plus 45 partially matching documents found.
Latest Intelligence
-
20 for 2020 – Five pharma leaders to watch in 2020
He replaced Scott Gottlieb, who was popular with industry but resigned from the post unexpectedly last year, as well as stand-in Ned Sharpless who has now returned to his post
-
Will biosimilars ever catch on in the US?
In the early days of the Trump administration, then-FDA commissioner Scott Gottlieb made a point of clearing the way for even faster and more generic approvals, again with some apparent ... Based on those assumed savings, had all the FDA-approved
-
Encouraging signs in biomarker R&D
The timing of the withdrawal was ironic given that, in the same month, FDA Commissioner Scott Gottlieb highlighted ‘TMB as a potential biomarker for enriching clinical trials testing immunotherapies’. ... Harmonisation. Gottlieb has since resigned,
-
Streamlining clinical trials – why better data use is key
Dr Scott Gottlieb’s brief, energetic tenure as US FDA Commissioner is likely to shape agency oversight of the pharmaceutical industry for years to come, particularly in relation to clinical development. ... To embrace innovations like blockchain, as
-
Cell and gene therapy
Interest in cell and gene therapies is undeniable. In January, US FDA Commissioner Scott Gottlieb outlined policies designed to accommodate an anticipated surge in cell and gene therapy submissions. ... Gottlieb highlighted manufacture as a challenge
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Medical Editor
-
Competitive Salary
-
Account Management
-
Competitive Salary Offered
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Account Manager
-
Competitive Salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Executive
-
Competitive Salary
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Senior Medical Writer
-
Competitive Salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
-
Associate Account Director
-
Competitive Salary
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Merck & Co reveals plans for women’s health spinoff Organon
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- bluebird bio aiming to separate business units by year-end
- InSite Events™ selected as an honorable mention in Fast Company’s 2021 World Changing Ideas Awards
- THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
- Moderna’s booster vaccines increase neutralising antibodies against COVID-19 variants
- FDA approval for Keytruda/Herceptin combination in first-line advanced gastric cancer
- US backs proposal to waive IP protection for COVID-19 vaccines
- Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Why female mentorship is so powerful in pharma
- CanSinoBIO considers booster jab for COVID-19 vaccine
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Moderna COVID-19 vaccine shortfall could affect UK supply
- NICE sets out plans for ‘ambitious’ five-year strategy
- Working in true partnership in a time of change
PMHub
Frontera Group
A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...
Latest intelligence
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
- Deep 6 AI: the smart software breathing new life into clinical trials
- Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
- COVID-proof: How Teams are Creating Launch Intensity thru Adversity
- Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....
